Last Published 10.01.2025 Effective Date: 10.01.2025 This policy addresses the use of Apretude (cabotegravir), Cabenuva (cabotegravir/rilpivirine), and Sunlenca (lenacapavir) for the treatment of a human immunodeficiency virus type-1 (HIV-1)
If you are like most people and do not have a special medical reason, what can you do now
This approach often shortens the time it takes to notice early improvements because the strategy fits the individual instead of forcing the body to adapt to a rigid plan
Block time on your calendar for meals and movement the way you would for a meeting
Choosing the Right GLP-1 Approach When exploring weight management options during menopause, you might be wondering about different GLP-1 medications, and which one could be right for you
Planning for Pregnancy After Ozempic Treatment If youre considering using Ozempic before pregnancy with a plan to conceive after reaching your weight goals, strategic planning helps